Advertisement

Fatty-acid SPECT imaging for assessment of myocardial viability

Chapter
  • 50 Downloads
Part of the Developments in Cardiovascular Medicine book series (DICM, volume 226)

Abstract

Because fatty acids are the preferred source of energy substrate by the contracting myocardium, fatty-acid imaging has been viewed with interest in the last four decades as a potential noninvasive means to explore the myocardial metabolism [1,2]. Over the years, a large number of iodine-labeled fatty acids have been tried either experimentally or clinically (Table 1). Yet, the clinical utilization of fatty-acid imaging in the United States has been hampered by the lack of a commercially available product as well as by uncertainties about the intrinsic mechanisms of uptake, concentration and release of different fatty acids by the myocytes. In Japan, the branched fatty acid iodine-123 methyl-pentadecanoic acid (BMIPP) is commercially available and has been used with some frequency.

Keywords

Single Photon Emission Compute Tomography Fatty Acid Uptake Pentadecanoic Acid BMIPP Uptake Myocardial Fatty Acid Metabolism 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Evans JR, Gunton RW, Baker RG et al. Use of radioiodinated fatty acid for photoscans of the heart. Circ Res 1965;16:1–10.PubMedCrossRefGoogle Scholar
  2. 2.
    Gunton RW, Evans JR, Baker RG, Spears JC, Beanlands DS. Demonstration of myocardial infarction by photoscans of the heart in man. Am J Cardiol 1965;16:482–487.PubMedCrossRefGoogle Scholar
  3. 3.
    Visser FC, Westera G, Van Eenige MJ, Van der Wall EE, Den Hollander W, Roos JP. The myocardial elimination rate of radioiodinated heptadecanoic acid. Eur J Nucl Med 1985;10:118–122.PubMedCrossRefGoogle Scholar
  4. 4.
    Van der Wall EE, Heidendal GA, den Hollander W, Westera G, Roos JP. I-123 labeled hexadecanoic acid in comparison with thallium-201 for myocardial imaging in coronary heart disease. Eur J Nucl Med 1980:5:401–405.PubMedCrossRefGoogle Scholar
  5. 5.
    Van der Wall EE, Heidendal GA, den Hollander W, Westera G, Roos JP. Metabolic myocardial imaging with 123-I labeled heptadecanoic acid in patients with angina pectoris. Eur J Nucl Med 1981;6:391–396.PubMedGoogle Scholar
  6. 6.
    Van der Wall EE, Heidendal GA, den Hollander W, Westera G, Roos JP. Myocardial scintigraphy with 123I-labeled heptadecanoic acid in patients with unstable angina pectoris. Postgrad Med J 1983;59 suppl 3:38–40.PubMedGoogle Scholar
  7. 7.
    Otto CA, Brown LE, Wieland DM, Beierwaltes WH. Radioiodinated fatty acids for myocardial imaging: effects of chain length. J Nucl Med 1981;22:613–618.PubMedGoogle Scholar
  8. 8.
    Machulla HJ, Marsmann M, Dutschka K. 131I-(phenyl)-pentadecanoic acid, a highly promising radioiodinated fatty acid for myocardial studies. I. Development of synthesis and radiophamaceutical quality. Radioaktive Isot Klin Forsch 1980;14:363–367.Google Scholar
  9. 9.
    Machulla HJ, Marsmann M, Dutschka K. Radiopharmaceuticals: synthesis of radioiodinated phynyl fatty acics for studying myocardial metabolism. J Radioanal Chem 1980;56:253–258.CrossRefGoogle Scholar
  10. 10.
    Kulkarni PV, Parkey RW. A new radioiodination method utilizating organothalium intermediate: Radioiodination of phereynypentadecanoic acid (PPA) for potential applications in myocardial imaging. J Nucl Med 1982;23 (6 suppl):p105.Google Scholar
  11. 11.
    Reske SN, Sauer W, Machulla HJ, Winkler C. 15(p-[123I]iodophenyl) pentadecanoic acid as a tracer of lipid metabolism: comparison with [1-14C] palmitic/acid in murine tissues. J Nucl Med 1984;25:1335–1342.PubMedGoogle Scholar
  12. 12.
    Reske SN, Sauer W, Machulla HJ, Knust J, Winkler C. Metabolism of 15 (p123I iodophenyl)-pentadecanoic acid in heart muscle and noncardiac tissues. Eur J Nucl Med 1985;10:228–234.PubMedCrossRefGoogle Scholar
  13. 13.
    Relias JS, Corbett JR, Kulkarni P et al. Iodine-123 phenylpentadecanoic acid: detection of acute myocardial infarction and injury in dogs using an iodinated fatty acid and single-photon emission tomography. Am J Cardiol 1983;52:1326–1332.CrossRefGoogle Scholar
  14. 14.
    Dudczak R, Schmoliner R, Kletter K, Frischauf H, Angelberger P. Clinical evaluation of 1231-labeled p-phenylpentadecanoic acid (p-IPPA) for myocardial scintigraphy. J Nucl Med Allied Sci 1983;27:267–279.PubMedGoogle Scholar
  15. 15.
    Wolfe CL, Kennedy PL, Kulkarni P, Jansen DE, Gabliani GI, Corbett JR. Iodine-123 phenylpentadecanoic acid myocardial scintigraphy in patients with left ventricular hypertrophy: alterations in left ventricular distribution and utilization. Am Heart J 1990;119:1338–1347.PubMedCrossRefGoogle Scholar
  16. 16.
    Kropp J, Likungu J, Kirchhoff PG et al. Single photon emission tomography imaging of myocardial oxidative metabolism with 15(p-[123]iodophynl) pentadecanoic acid in patients with coronary artery disease and aorto-coronary bypass graft surgery. Eur J Nucl Med 1991;18:467–474.PubMedCrossRefGoogle Scholar
  17. 17.
    Kennedy PL, Corbett JR, Kulkarni PV et al. Iodine 123-phenylpentadecanoic acid myocardial scintigraphy: usefulness in the identification of myocardial ischemia. Circulation 1986;74:1007–1015.PubMedCrossRefGoogle Scholar
  18. 18.
    Hansen CL, Corbett JR, Pippin JJ et al. Iodine-123 phenylpentadecanoic acid and single-photon emission computed tomography in identifying left ventricular regional metabolic abnormalities in patients with coronary heart disease: comparison with thallium-201 myocardial tomography. J Am Coll Cardiol 1988;12:78–87.PubMedCrossRefGoogle Scholar
  19. 19.
    Schad N, Daus HJ, Ciavolella M, Maccio H. Noninvasive functional imaging of regional rate of myocardial fatty acids metabolism. Cardiologia 1987;32:239–247.PubMedGoogle Scholar
  20. 20.
    Ugolini V, Hansen CL, Kulkarni PV, Jansen DE, Akers MS, Corbett JR. Abnormal myocardial fatty acid metabolism in dilated cardiomyopathic detected by Iodine-123 phenylpentadecanoic acid and tomographic imaging. Am J Cardiol 1988;62:923–928.PubMedCrossRefGoogle Scholar
  21. 21.
    Murray G, Schad N, Ladd W et al. Metabolic cardiac imaging in severe coronary disease: assessment of viability with iodine-123I-Iodophenyl-pentadecanoic acid and multicrystal gamma camera, and correlation with biopsy. J Nucl Med 1992;33:1269–1277.PubMedGoogle Scholar
  22. 22.
    Iskandrian AS, Powers J, Cave V, Wasserleben V, Cassell D, Heo J. Assessment of myocardial viability by dynamic tomographic iodine 123 iodophenylpentadecanoic acid imaging: comparison with rest-redistribution thallium 201 imaging. J Nucl Cardiol 1995;2:101–109.PubMedGoogle Scholar
  23. 23.
    Verani MS, Taillefer R, Iskandrian AE, Mahmarian JJ, He ZX, for the Multicenter IPPA Viability Trial Investigators. I-123 Iodophenylpentadecanoic Acid (IPPA) single photon emission tomography for the prediction of enhanced left ventricular function after coronary bypass graft surgery. Submitted for publication, 1998.Google Scholar
  24. 24.
    Knapp FF Jr, Kropp J. Iodine-123-labelled fatty acids for myocardial single-photon emission tomography: current status and future perspectives. Eur J Nucl Med 1995;22:361–381.PubMedCrossRefGoogle Scholar
  25. 25.
    Nohara R, Okuda K, Ogino M et al. Evaluation of myocardial viability with iodine-123-BMIPP in a canine model. J Nucl Med 1996;37:1403–1407.PubMedGoogle Scholar
  26. 26.
    Fujibayashi Y, Yonekura Y, Takemura Y et al. Myocardial accumulation of iodinated beta-methyl-branched fatty acid analogue, iodine-125-15-(p-iodophenyl)-3-(R,S) methylpentadecanoic acid (BMIPP), in relation to ATP concentration. J Nucl Med 1990;31:1818–1822.PubMedGoogle Scholar
  27. 27.
    Hosokawa R, Nohara R, Fujibayashi Y et al. Myocardial kinetics of iodine-123-BMIPP in canine myocardium after regional ischemia and reperfusion: implications for clinical SPECT. J Nucl Med 1997;38:1857–1863.PubMedGoogle Scholar
  28. 28.
    Dormehl IC, Hugo N, Rossouw D, White A, Feinendengen LE. Planar myocardial imaging in the baboon model with iodine-123-15-(iodophenyl) pentadecanoic acid (IPPA) and iodine-123-15-(P-Iodophenyl)-3-R,S-methylpentadecanoic acid (BMIPP), using time-activity curves for evaluation of metabolism. Nucl Med Biol 1995;22:837–847.PubMedCrossRefGoogle Scholar
  29. 29.
    Kurata C, Wakabayashi Y, Shouda S et al. Influence of blood substrate levels on myocardial kinetics of iodine-123-BMIPP. J Nucl Med 1997;38:1079–1084.PubMedGoogle Scholar
  30. 30.
    Tateno M, Tamaki N, Yukihiro M et al. Assessment of fatty acid uptake in ischemic heart disease without myocardial infarction. J Nucl Med 1996;37:1981–1985.PubMedGoogle Scholar
  31. 31.
    Fujiwara S, Takeishi Y, Atsumi H, Takahashi K, Tomoike H. Fatty acid metabolic imaging with Iodine-123-BMIPP for the diagnosis of coronary artery disease. J Nucl Med 1997;38:175–180.PubMedGoogle Scholar
  32. 32.
    Takeishi Y, Fujiwara S, Atsumi H, Takahashi K, Sukekawa H, Tomoike H. Iodine-123-BMIPP imaging in unstable angina: a guide for interventional strategy. J Nucl Med 1997;38:1407–1411.PubMedGoogle Scholar
  33. 33.
    Taki J, Nakajima K, Matsunari I et al. Assessment of improvement of myocardial fatty acid uptake and function after revascularization using iodine-123-BMIPP. J Nucl Med 1997;38:1503–1510.PubMedGoogle Scholar
  34. 34.
    Kobayashi H, Kusakabe K, Momose M et al. Evaluation of myocardial perfusion and fatty acid uptake using a single injection of iodine-123-BMIPP in patients with acute coronary syndromes. J Nucl Med 1998;39:1117–1122.PubMedGoogle Scholar
  35. 35.
    De Geeter F, Franken PR, Knapp FF Jr, Bossuyt A. Relationship between blood flow and fatty acid metabolism in subacute myocardial infarction: a study by means of 99mTc-Sestamibi and 123I-beta-methyl-iodo-phenyl pentadecanoic acid. Eur J Nucl Med 1994;21:283–291.PubMedCrossRefGoogle Scholar
  36. 36.
    Ito T, Tanouchi J, Kato J et al. Recovery of impaired left ventricular function in patients with acute myocardial infarction is predicted by the discordance in defect size on 123I-BMIPP and 201Tl SPET images. Eur J Nucl Med 1996;23:917–923.PubMedCrossRefGoogle Scholar
  37. 37.
    Tamaki N, Tadamura E, Kudoh T et al. Prognostic value of iodine-123 labelled BMIPP fatty acid analogue imaging in patients with myocardial infarction. Eur J Nucl Med 1996;23:272–279.PubMedCrossRefGoogle Scholar
  38. 38.
    Taki J, Nakajima K, Matsunari I, bunko H, Takada S, Tonami N. Impairment of regional fatty acid uptake in relation to wall motion and thallium-201 uptake in ischaemic but viable myocardium; assessment with iodine-123-labelled beta-methyl-branched fatty acid. Eur J Nucl Med 1995;22:1385–1392.PubMedCrossRefGoogle Scholar
  39. 39.
    Sloof GW, Visser FC, Bax JJ et al. Increased uptake of iodine-123-BMIPP in chronic ischemic heart disease: comparison with fluorine-18-FDG SPECT. J Nucl Med 1998;39:255–260.PubMedGoogle Scholar
  40. 40.
    Haque T, Furukawa T, Yoshida S et al. Echocardiography and fatty acid single photon emission tomography in predicting reversibility of regional left ventricular dysfunction after coronary angioplasty. Eur Heart J 1998;19:332–341.PubMedCrossRefGoogle Scholar
  41. 41.
    Nakata T, Hashimoto A, Kobayashi H et al. Outcome significance of thallium-201 and iodine-123-BMIPP perfusion — metabolism mismatch in preinfarction angina. J Nucl Med 1998;39:1492–1499.PubMedGoogle Scholar
  42. 42.
    Mori T, Hayakawa M, Hattori K et al. Exercise beta-methyl iodophenyl pentadecanoic acid (BMIPP) and resting thalium delayed single photon emission computed tomography (SPECT) in the assessment of ischemia and viability. Jpn Circ J 1996;60:17–26.PubMedCrossRefGoogle Scholar
  43. 43.
    Tadamura E, Kudoh T, Hattori N et al. Impairment of BMIPP uptake precedes abnormalities in oxygen and glucose metabolism in hypertrophic cardiomyopathy. J Nucl Med 1998;39:390–396.PubMedGoogle Scholar
  44. 44.
    Matsuo S, Nakamura Y, Takahashi M, Mitsunami K, Kinoshita M. Myocardial metabolic abnormalities in hypertrophic cardiomyopathic assessed by iodine-123-labeled beta-methyl-branched fatty acid myocardial scintigraphy and its relation to exercise-induced ischemia. Jpn Circ J 1998;62:167–172.PubMedCrossRefGoogle Scholar
  45. 45.
    Shimizu M, Yoshio H, Ino H et al. Myocardial scintigraphic study with 123I 15-(p-iodophenyl)-3(R,S)-methylpentadecanoic acid in patients with hypertrophic cardiomyopathy. Int J Cardiol 1996;54:51–59.PubMedCrossRefGoogle Scholar
  46. 46.
    Kudoh T, Tamaki N, Magata Y et al. Metabolism substrate with negative myocardial uptake of iodine-123-BMIPP. J Nucl Med 1997;38:548–553.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2000

Authors and Affiliations

There are no affiliations available

Personalised recommendations